how to start retatrutide peptide 20mg: complete dosing and reconstitution guide Retatrutide Research Concentration Overview |
Description
Research forecasts project the GLP-1 market to grow from around USD 62 billion in 2025 to ~USD 157 billion by 2035 (CAGR ~9.7%) ( [7] ), with North America and Asia leading growth.JPMorgan recently estimated that approximately 25 million Americans could be on GLP-1 treatment by 2030 , up from about 10 million in 2025 (and only ~5 million in 2023) ( [8] )
The remaining patients rely on commercial insurance to access branded options
Semaglutide has received FDA approval for cardiovascular event risk reduction in 2020 and, most recently, kidney disease risk reduction in 2025 [14, 15, 3032]
It is not a weight-loss drug and does not promise weight loss
What are the expected side effects of retatrutide
Primary-Care Referrals: Your doctor can connect you with certified GLP-1 networks for ongoing care and progress tracking
